These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 3048454)
21. [Omeprazole in the therapy of acid-induced diseases]. Simon B; Dammann HG; Müller P Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299 [TBL] [Abstract][Full Text] [Related]
22. Cimetidine in the management of peptic ulcer disease. Dyck WP Surg Clin North Am; 1979 Oct; 59(5):863-7. PubMed ID: 390744 [No Abstract] [Full Text] [Related]
23. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders. Barradell LB; Faulds D; McTavish D Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017 [TBL] [Abstract][Full Text] [Related]
24. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase. McArthur KE; Jensen RT; Gardner JD Annu Rev Med; 1986; 37():97-105. PubMed ID: 3010811 [TBL] [Abstract][Full Text] [Related]
28. Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h. Hirschowitz BI; Mohnen J; Shaw S Aliment Pharmacol Ther; 1996 Aug; 10(4):497-506. PubMed ID: 8853753 [TBL] [Abstract][Full Text] [Related]
30. The impact of cimetidine on the treatment of acid-peptic disease. Fleshler B Prim Care; 1981 Jun; 8(2):195-203. PubMed ID: 7027288 [No Abstract] [Full Text] [Related]
31. [Histamine H2 receptor antagonists. Pharmacology and clinical applications]. Mignon M; Gislon J; Bonfils S Rev Prat; 1978 Nov; 28(53):4145-6, 4151-2, 4155-8. PubMed ID: 33441 [No Abstract] [Full Text] [Related]
32. Omeprazole in gastric and duodenal ulcers. Savarino V; Mela GS; Celle G Gut; 1991 Jun; 32(6):721. PubMed ID: 2060885 [No Abstract] [Full Text] [Related]
33. Omeprazole in the long-term management of patients with acid-related diseases resistant to ranitidine. Brunner G; Creutzfeldt W Scand J Gastroenterol Suppl; 1989; 166():101-5; discussion 111-3. PubMed ID: 2513641 [TBL] [Abstract][Full Text] [Related]
34. Cimetidine. I. Developments, pharmacology, and efficacy. Freston JW Ann Intern Med; 1982 Oct; 97(4):573-80. PubMed ID: 6751184 [TBL] [Abstract][Full Text] [Related]
35. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis. Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110 [TBL] [Abstract][Full Text] [Related]
36. [Experience in the use of losek (omeprazole) in gastroenterology]. Maev IV; V'iuchnova ES; Lebedev EG; Dicheva DT; Ovsiannikova EV; Antonenko OM; Shchekina MI Ter Arkh; 2001; 73(7):79-82. PubMed ID: 11523419 [No Abstract] [Full Text] [Related]
37. Is there a need for strong gastric acid inhibition in clinical practice? Lamers CB Digestion; 1989; 44 Suppl 1():4-8. PubMed ID: 2691309 [TBL] [Abstract][Full Text] [Related]
38. [Omeprazole in peptic ulceration: acid inhibition and endoscopic healing]. Chen SP; Mai CR; Ke MY Zhonghua Nei Ke Za Zhi; 1989 Dec; 28(12):720-1, 767. PubMed ID: 2636088 [TBL] [Abstract][Full Text] [Related]